FDA Clearance Tracker · K201326
Psychemedics Homogeneous Enzyme Immunoassay (HEIA) for Opiates in Hair, Psychemedics Homogeneous Enzyme Immunoassay (HEIA) for Oxycodone in Hair
Last checked: Nov 20, 2026Latest source record: Jul 27, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Jul 27, 2021
Substantially Equivalent
Time to decision
434 days
Received May 19, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K201326
- Device name
- Psychemedics Homogeneous Enzyme Immunoassay (HEIA) for Opiates in Hair, Psychemedics Homogeneous Enzyme Immunoassay (HEIA) for Oxycodone in Hair
- Applicant
- Psychemedics Corporation
- Applicant location
- Culver City, CA
- Received
- May 19, 2020
- Decided
- Jul 27, 2021
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Enzyme Immunoassay, Opiates (DJG)
- Device class
- Class II
- Regulation
- 21 CFR 862.3650
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DJG. The earliest in FDA's data is K833581, decided Jan 26, 1984.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K201326
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Psychemedics Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K212952 · Decided Apr 18, 2022 · 214 days after receipt
Device type: Enzyme Immunoassay, Phencyclidine (LCM) · Laboratory Medicine & Pathology
K210212 · Decided Dec 15, 2021 · 322 days after receipt
Device type: Gas Chromatography, Methamphetamine (LAF) · Laboratory Medicine & Pathology
K201228 · Decided Jun 25, 2021 · 414 days after receipt
Device type: Enzyme Immunoassay, Cocaine (JXO) · Laboratory Medicine & Pathology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.